(155 days)
The Datex-Ohmeda TruSat Pulse Oximeter and Accessories is indicated for spotchecking and continuous monitoring of functional oxygen saturation and pulse rate, including monitoring during conditions of clinical patient motion or low perfusion. These devices are intended for use with adult, pediatric and neonatal patients in both hospital and non-hospital environments.
The TruSat is the next generation in the Datex-Ohmeda Pulse Oximeter family of products. The Datex-Ohmeda 3800 Series and 3900 Series Pulse Oximeters and Accessories with TruTrak Plus Enhancements and the Datex-Ohmeda TruSat Pulse Oximeter and Accessories are substantially equivalent in design concepts, technologies and materials. The TruSat was validated through rigorous testing that, in part, support the compliance of the TruSat to the above mentioned standards. Additionally, the software for the TruSat was developed following a robust software development process and was fully specified and validated.
The provided text does not contain detailed information regarding acceptance criteria, a specific study proving device performance, sample sizes for test or training sets, data provenance, expert ground truth establishment, or adjudication methods for the Datex-Ohmeda TruSat Pulse Oximeter.
The document is a 510(k) summary for premarket notification, primarily focusing on establishing substantial equivalence to previously cleared devices and compliance with relevant standards. It mentions "rigorous testing" and "fully specified and validated" software but does not elaborate on the specifics of these tests in a way that would allow for a detailed answer to your request.
Therefore, I cannot provide the requested table or detailed information on the study as the input text does not contain this data.
The summary states:
- "The TruSat was validated through rigorous testing that, in part, support the compliance of the TruSat to the above mentioned standards."
- "Additionally, the software for the TruSat was developed following a robust software development process and was fully specified and validated."
These statements indicate that testing and validation occurred, but they do not provide the detailed output or methods of those tests to answer your specific questions about acceptance criteria or study specifics.
{0}------------------------------------------------
March 29th, 2004
| Subject: | 510(k) Summary of Safety and Effectiveness Information for the Datex-OhmedaTruSat Pulse Oximeter and Accessories |
|---|---|
| Submitter: | Datex-Ohmeda, Inc1315 West Century DriveLouisville, CO |
| Contact:Phone:Fax: | Mr. Scott Light1 800 652 2469, Ext 15021 303 665 9176 |
| Proprietary:Common:Classification: | Datex-Ohmeda TruSat Pulse Oximeter and AccessoriesOximeterClass II, 21 CFR §870.2700, 74 DQA |
The 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of SMDA 1990 and 1992.
The TruSat substantially equivalent to the FDA cleared and currently marketed Datex-Ohmeda 3800 Series and 3900 Series Pulse Oximeters and Accessories with TruTrak Plus Enhancements (K021955).
The TruSat pulse oximeter is indicated for spot-checking and continuous monitoring of functional oxygen saturation and pulse rate, including monitoring conditions of clinical patient motion1 or low perfusion. This device is intended for use with adult, pediatric, and neonatal patients in both hospital and non-hospital environments.
The TruSat is designed to comply with the following standards:
- IEC 60601-1: 1988, Am1: 1991, Am2: 95 .
- IEC 60601-1-1: 2000 .
- IEC 60601-1-2: 2001 .
- . IEC 60601-1-4: 2000
- IEC 60601-1-8: 2003 (62A/424/FDIS) .
- . ISO 9919: 1992
- CSA C22.2 #601.1 M90 (R2001) .
- UL 2601-1: 1997 .
The Datex-Ohmeda 3800 Series and 3900 Series Pulse Oximeters and Accessories with TruTrak Plus Enhancements and the Datex-Ohmeda TruSat Pulse Oximeter and Accessories are substantially equivalent in design concepts, technologies and materials. The TruSat was validated through rigorous testing that, in part, support the compliance of the TruSat to the above mentioned standards. Additionally, the software for the TruSat was developed following a robust software development process and was fully specified and validated.
The TruSat is the next generation in the Datex-Ohmeda Pulse Oximeter family of products.
Datex-Ohmeda, Inc. P.O. Box 7550 Madison, WI 53707 7550 www.datex-ohmeda.com
Telephone 608-221-1551 Toll Free 800-345-2700 Facsimile 608-222-9147
{1}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles three abstract shapes or lines, possibly representing people or services.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP = 2 2004
Mr. Scott Light Ouality Assurance Manager Datex-Ohmeda, Incorporated 1315 West Century Drive Louisville, Colorado 80027-9560
Re: K040831
Trade/Device Name: Datex-Ohmeda TruSat Pulse Oximeter and Accessories, Model Regulation Number: 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DPZ Dated: August 18, 2004 Received: August 19, 2004
Dear Mr. Light:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{2}------------------------------------------------
Page 2 - Mr. Light
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Chiu Lin, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
510(k) Number (if known): K
Device Name: Datex-Ohmeda TruSat Pulse Oximeter and Accessories
Indications For Use:
The Datex-Ohmeda TruSat Pulse Oximeter and Accessories is indicated for spotchecking and continuous monitoring of functional oxygen saturation and pulse rate, including monitoring during conditions of clinical patient motion or low perfusion.
These devices are intended for use with adult, pediatric and neonatal patients in both hospital and non-hospital environments.
Prescription Use XXX (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Aingusion
Page 1 of
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number:
§ 870.2710 Ear oximeter.
(a)
Identification. An ear oximeter is an extravascular device used to transmit light at a known wavelength(s) through blood in the ear. The amount of reflected or scattered light as indicated by this device is used to measure the blood oxygen saturation.(b)
Classification. Class II (performance standards).